This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Alcon Research, Ltd., Arrowhead Pharmaceuticals, Inc., Arrowhead Research Corporation. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Forth Worth, TX (US) (2014)
- Fort Worth, TX (US) (2014 - 2016)
Company Filing History:
2 out of 348 
1 out of 102 
1 out of 18 Years Active: 2014-2016
Title: The Innovative Contributions of Adrian M Timmers
Introduction
Adrian M Timmers is a notable inventor based in Fort Worth, TX (US). He has made significant contributions to the field of biomedical research, particularly in the area of ocular health. With a total of 4 patents to his name, Timmers has focused on innovative solutions for treating conditions related to tumor necrosis factor alpha (TNF-alpha).
Latest Patents
One of Timmers' latest patents involves RNAi-related inhibition of the TNF-alpha signaling pathway for the treatment of ocular angiogenesis. This invention utilizes RNA interference to inhibit TNF-alpha by silencing the mRNA expression of the TNF receptor-1 (TNFR1) and the TNF-alpha converting enzyme (TACE/ADAM17). Such silencing is particularly beneficial for patients suffering from TNF-alpha-related conditions, including ocular angiogenesis, retinal ischemia, and diabetic retinopathy.
Career Highlights
Throughout his career, Adrian M Timmers has worked with prominent companies in the pharmaceutical and research sectors. Notably, he has been associated with Alcon Research, Ltd. and Arrowhead Pharmaceuticals, Inc. His work in these organizations has contributed to advancements in medical treatments and therapies.
Collaborations
Timmers has collaborated with several professionals in his field, including Jon E Chatterton and Abbot F Clark. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Adrian M Timmers exemplifies the spirit of innovation in the biomedical field. His work on RNAi-related therapies showcases his commitment to improving patient outcomes in ocular health. Through his patents and collaborations, Timmers continues to make a lasting impact on medical research and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile